Suh JK, et al. – The topic of examination here was the role of hematopoietic stem cell transplantation (HSCT) in pediatric patients with acute myeloid leukemia (AML), without favorable cytogenetics. It was displayed that the low TRM rate and encouraging outcomes were indicative of HSCT possibly serving as a feasible therapy for such patients.